Navigation Links
Investigational agent targets gene signaling pathways to improve response for patients with CLL
Date:12/8/2012

uch patients are characterized by presence of chromosomal abnormalities (i.e., deletions of chromosome 17p or 11q) or short remissions (less than 3 years) after standard chemo-immunotherapy. To develop an alternative therapy regimen for this patient population, researchers explored the combination of ibrutinib and the anti-CD20 antibody rituximab in high-risk CLL.

In this Phase II study conducted at The University of Texas MD Anderson Cancer Center in Houston, ibrutinib was given in combination with rituximab to evaluate its potential to accelerate and improve CLL patient responses. Forty patients were treated with 420 mg of ibrutinib daily in combination with weekly rituximab for four weeks, followed by ibrutinib daily plus monthly rituximab until month six, followed by single-agent ibrutinib.

Positive responses to therapy were shown among the vast majority of treated patients. At four months of follow-up, the overall response rate was 85 percent and almost all (38 of 40) patients continued on therapy without disease progression. Of the 20 patients evaluable for early response, 17 achieved a partial remission. Patient health questionnaires also noted improvements in health and the quality of life of all treated patients.

Overall, the regimen was well-tolerated among participants, with little severe toxicity that was largely unrelated and short in duration. After treatment with ibrutinib-rituximab (iR) combination therapy, most cases of early lymphocytosis (increase in white blood cells that is a sign of infection), due to the ibrutinib-induced shift of CLL cells from lymph node tissues into the blood, peaked early and resolved; at four months of follow-up, only three treated patients had lymphocytosis that had not yet resolved. This shorter lymphocytosis duration, when compared to single-agent use of ibrutinib, is presumably related to the addition of rituximab.

"We know that high-risk CLL patients struggle with the effects of
'/>"/>

Contact: Andrea Slesinski
aslesinski@hematology.org
614-352-5096
American Society of Hematology
Source:Eurekalert

Page: 1 2 3 4 5 6

Related medicine news :

1. Updated Clinical Results Show Experimental Agent Ibrutinib as Highly Active in CLL Patients
2. Rilpivirine for HIV: Added benefit for single agent proven
3. Travel Services (MyTSOnline) in Valencia Teams Up With Vendors to Become the Number One Travel Agent in the Santa Clarita Valley
4. Mayo Clinic gets FDA approval for new imaging agent for recurrent prostate cancer
5. Scientists ID Cancer-Causing Agent in Smokeless Tobacco
6. Therapy combining exercise and neuroprotective agent shows promise for stroke victims
7. New substances 15,000 times more effective in destroying chemical warfare agents
8. Difficult to diagnose cases of infectious endocarditis solved with SPECT/CT imaging agent
9. Imaging agents predict breast cancer response to endocrine therapy
10. Pig stomach mucins are effective as anti-viral agents for consumer products
11. Method developed by VTT targets diagnosis of early Alzheimers disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... ... ... After wearing the same uniforms for six seasons, the Sprayberry High School girls ... the team, the Jones Agency, a locally owned insurance firm that serves communities in ... uniforms. , As is so often the case with high school and many school-related ...
(Date:9/4/2015)... ... September 04, 2015 , ... A ... Compassion Project. Core Compassion Project is a non-profit organization dedicated to offering ... side effects of cancer treatments and recover their mobility, strength, and range of ...
(Date:9/4/2015)... ... 2015 , ... Keeping mold top of mind is important when considering indoor ... can grow anywhere - on carpet, clothing, food, paper, and even in places you ... in the home is key to preventing mold growth, which if exposed to can ...
(Date:9/4/2015)... ... 2015 , ... “Getting away from the daily stressors and distractions of life ... their ‘couple-ness,’” says Jean Claude Wietzel, general manager at Four Seasons Resort Maui ... only Forbes Five Star resort and Travel + Leisure’s No. 1 Hotel in Hawaii, ...
(Date:9/4/2015)... , ... September 04, 2015 , ... Many consumers are looking for a quick and ... their solution. , The patent-pending K Med Cups provide a quick and simple way to ... relieve a cold, flu or cough. As a result, they enhance comfort and health. The ...
Breaking Medicine News(10 mins):Health News:The Jones Agency Serves Up a Charity Drive to Fund New Uniforms for the Sprayberry High School Girls Volleyball Team 2Health News:The Jones Agency Serves Up a Charity Drive to Fund New Uniforms for the Sprayberry High School Girls Volleyball Team 3Health News:Girl’s Night Out to Benefit Core Compassion Project, Located at the Beautiful, Morning Glory Farm 2Health News:September is Mold Awareness Month 2Health News:September is Mold Awareness Month 3Health News:September is Mold Awareness Month 4Health News:Couples Season at Four Seasons Resort Maui Begins This Week With Best Hotel Rates of the Year through November 2Health News:Couples Season at Four Seasons Resort Maui Begins This Week With Best Hotel Rates of the Year through November 3Health News:Redesigned Packaging for Powdered Medicinal Mix Invented by InventHelp® Client (CBA-2637) 2
... ATS Medical, Inc.,(Nasdaq: ATSI ), manufacturer and ... announced that James L. Cox, M.D. has,agreed to ... reputation as a,preeminent authority in the surgical treatment ... as the foundation for ATS 3f(R),tissue valve technologies, ...
... (Pink Sheets: MSITF) predicts that revenues will exceed,4.0 million ... 2008) of its fiscal,year. The predicted revenues are based ... internet sales that the Company expects in the second,half., ... has developed several new,products that will be available on ...
... Md., Dec. 11 Panacea Pharmaceuticals,Inc. has initiated ... for prostate cancer, under GMP conditions. Data on ... included in a Premarket,Approval (PMA) application for this ... and Drug Administration in early 2008. To date, ...
... Dec. 11 Surgical Care,Affiliates ("SCA") today announced ... 10:00 a.m. Eastern Time on Friday, December 14, ... quarter of 2007. Please go to SCA,s,Intralinks website ... the,conference call or contact Kathleen Vojta at (205) ...
... (Nasdaq:,BIOD) today reported fourth quarter and fiscal year ... and disclosed 2008,objectives., "In 2007, our first ... pipeline,and achieved critical corporate objectives," stated Dr. Solomon ... reached include our,successful initial public offering, the issuance ...
... of Families with Deployed Service Members ... ... exclusive sponsor of the,Military Child Education Coalition,s Supporting the Children of the,National ... present $25,000 to the Minuteman Emergency,Assistance Fund. The contribution will help support ...
Cached Medicine News:Health News:ATS Medical Appoints James L. Cox, M.D. as Medical Director 2Health News:ATS Medical Appoints James L. Cox, M.D. as Medical Director 3Health News:Medical Services International Predicts Revenues for the Second Half of the Year 2Health News:Panacea Pharmaceuticals Initiates GMP Manufacturing of Prostate Cancer Diagnostic Test Kits 2Health News:Panacea Pharmaceuticals Initiates GMP Manufacturing of Prostate Cancer Diagnostic Test Kits 3Health News:Panacea Pharmaceuticals Initiates GMP Manufacturing of Prostate Cancer Diagnostic Test Kits 4Health News:Biodel Inc. Reports Fourth Quarter and Fiscal Year 2007 Financial Results 2Health News:Biodel Inc. Reports Fourth Quarter and Fiscal Year 2007 Financial Results 3Health News:Biodel Inc. Reports Fourth Quarter and Fiscal Year 2007 Financial Results 4Health News:Biodel Inc. Reports Fourth Quarter and Fiscal Year 2007 Financial Results 5Health News:Biodel Inc. Reports Fourth Quarter and Fiscal Year 2007 Financial Results 6Health News:Biodel Inc. Reports Fourth Quarter and Fiscal Year 2007 Financial Results 7Health News:Biodel Inc. Reports Fourth Quarter and Fiscal Year 2007 Financial Results 8Health News:Biodel Inc. Reports Fourth Quarter and Fiscal Year 2007 Financial Results 9Health News:TriWest Contributes $25,000 to Washington National Guard Fund and Sponsors Education for Teachers of Military Children 2
(Date:9/4/2015)... , September 4, 2015 ... Research Report is a professional and in-depth study ... Gown industry with a focus on the Chinese ... working days once an order is placed. ... across 150 pages, analyzing and profiling 8 major ...
(Date:9/4/2015)... , Sept. 4, 2015  Cumberland Pharmaceuticals (CPIX), today ... present live at VirtualInvestorConferences.com on September 10, 2015. ... ET LINK: http://tinyurl.com/sep10pre ... investors are invited to ask the company questions in ... as the association,s "virtual trade booth." If attendees are ...
(Date:9/4/2015)... Sept. 4, 2015  IGI Laboratories, Inc. (NYSE MKT: ... specialty generic pharmaceutical company, today announced it has submitted ... U.S. Food and Drug Administration (FDA) of 2015, which ... pending at the FDA to twenty-nine. ... commented, "We believe our current pipeline of twenty-nine submissions, ...
Breaking Medicine Technology:Surgical Gown Market 2020 Forecasts With a Focus on China 2Surgical Gown Market 2020 Forecasts With a Focus on China 3Surgical Gown Market 2020 Forecasts With a Focus on China 4Cumberland Pharmaceuticals to Webcast, Live, at VirtualInvestorConferences.com September 10 2IGI Laboratories, Inc. Announces Seventh ANDA Submission Of 2015 2
... 5, 2011 BD (Becton, Dickinson and Company) (NYSE: ... will host a live webcast of its Annual Meeting of Shareholders ... The webcast can be accessed from the BD corporate website ... Tuesday, February 8, 2011. About BDBD is ...
... BEDMINSTER, N.J., Jan. 5, 2011 Omthera Pharmaceuticals, ... announced that Jerry Wisler, President and Chief Executive ... Morgan Healthcare Conference at the Westin St. Francis ... 13, 2011 at 10:30am PT. ...
Cached Medicine Technology:
Injector blades come ten to an injector and allow for the easy replacement of Vibratome cutting blades....
Vibratome Specimen Adhesive is a special formulation developed by a major adhesive manufacturer for applications such as tissue mounting. The advantage of this adhesive is that it has a strong holdi...
... Deluxe specimen bath mounts inside the existing black ... for the separation of buffer and ice kept ... can be sterilized and has round mounting disks ... The disks and bath surface are marked ...
Punch set for Advanced Tissue Arrayer, 1.5 mm...
Medicine Products: